Evidence map›Paper›PMID 41893161›Full record

ReviewJournal of fungi (Basel, Switzerland)2026

Aspergillosis: An Update on Epidemiology, Risk Factors, Diagnosis, Susceptibility, and Treatment.

Carlos Alberto Castro-Fuentes, Juan Pablo Cabrera-Guerrero, Esperanza Duarte-Escalante, Graciela Hernández Silva, Alberto Chinney Herrera, María Del Rocío Reyes-Montes

Abstract readReview
In one paragraph

Review in Journal of fungi (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Carlos Alberto Castro-FuentesPosgrado en Ciencias Biológicas, Facultad de Medicina, Universidad Nacional Autónoma de Mexico (UNAM), Ciudad Universitaria, Avenida Universidad 3000, Coyoacán, Mexico City 04510, Mexico.ORCID 0000-0002-1277-7170
Juan Pablo Cabrera-GuerreroServicio de Microbiología, Instituto Nacional de Enfermedades Respiratorias "Ismael Cosío Villegas" (INER), Calz. de Tlalpan 4502, Belisario Domínguez Secc 16, Tlalpan, Mexico City 14080, Mexico.
Esperanza Duarte-EscalanteDepartamento de Microbiología y Parasitología, Facultad de Medicina, Universidad Nacional Autónoma de Mexico (UNAM), Ciudad Universitaria, Avenida Universidad 3000, Coyoacán, Mexico City 04510, Mexico.ORCID 0000-0002-6315-7860
Graciela Hernández SilvaServicio de Infectología, Instituto Nacional de Enfermedades Respiratorias "Ismael Cosío Villegas" (INER), Calz. de Tlalpan 4502, Belisario Domínguez Secc 16, Tlalpan, Mexico City 14080, Mexico.
Alberto Chinney HerreraCentro Nacional de Prevención y Control de Enfermedades (CENAPRECE), Francisco de P. Miranda No. 157, Col. Unidad Lomas de Plateros, Álvaro Obregón, Mexico City 01480, Mexico.ORCID 0000-0003-4109-7817
María Del Rocío Reyes-MontesDepartamento de Microbiología y Parasitología, Facultad de Medicina, Universidad Nacional Autónoma de Mexico (UNAM), Ciudad Universitaria, Avenida Universidad 3000, Coyoacán, Mexico City 04510, Mexico.ORCID 0000-0002-3866-9995

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aspergillosis is one of the most common fungal infections worldwide, caused by various species belonging to the genus

Indexed as

aspergillosisdiagnosisepidemiologyrisk factorssusceptibilitytreatment

Identifiers

PMID41893161
PMCPMC13027440

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.